NSQIP 30-day Outcome Measures for Below-knee Amputations by ICD-10 Diagnoses

Overview

Journal Surg Pract Sci

Date 2025 Jan 23

PMID 39845298

Authors

Jonathon Florance

Daniel Evans

Albert T Anastasio

Jacob Torrey

Christian Pean

Affiliations

Soon will be listed here.

Abstract

Background: The indications for Below-Knee Amputation (BKA) are expansive and etiologic subgroups are not well defined. This analysis uses primary ICD-10 diagnosis codes to stratify patients undergoing BKA, and examines differences in subgroup characteristics and 30-day outcomes.

Methods: We performed a retrospective analysis of patients in the NSQIP database who underwent BKA between 2015 and 2020. Approximately 80% of the 12,157 NSQIP BKA entries with primary ICD-10 diagnosis codes were stratified to diabetic ( = 3,363), vascular ( = 3,632), or infectious ( = 2,743) etiological subgroups.

Results: Patients with vascular etiologies were older, more likely to be female, underweight, ASA classification of four, and active tobacco users than patients in the other groups. Across all groups, there were incidences of 37.5% for 30-day inpatient complications, 7.0% for Clavien-Dindo Grade IV 30-day complications, 10.2% for 30-day readmission, and 4.2% for 30-day mortality. On bivariate analysis, infectious patients had the highest incidences of inpatient complications (38.6%, = 0.030) and Clavien-Dindo Grade IV complications (7.8%, = 0.055). Patients in the vascular group had the highest rates of readmission (12.7%, <0.001) and mortality (4.9%, = 0.006). In multivariate analysis, infectious etiology was an independent risk factor for 30-day mortality with an odds ratio of 1.48 (1.11-19.6, = 0.007).

Conclusions: Despite significant clinical overlap of diabetic, vascular, and infectious etiologies of BKA, this study demonstrates that these patients can be grouped by primary ICD-10 code with statistically significant differences in patient characteristics and 30-day outcomes. Further delineation by etiology could focus clinical and research efforts.

References

Hornung F, Rogal J, Loskill P, Loffler B, Deinhardt-Emmer S . The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections. Int J Mol Sci. 2021; 22(7). PMC: 8037155. DOI: 10.3390/ijms22073456. View

Florance J, Anastasio A, Adams S . Letter to the editor and commentary on the following manuscript: "Risk factors for reoperation, readmission, and early complications after below knee amputation". Injury. 2022; 54(2):794. DOI: 10.1016/j.injury.2022.12.006. View

Wrobel J, Mayfield J, Reiber G . Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care. 2001; 24(5):860-4. DOI: 10.2337/diacare.24.5.860. View

Thorud J, Plemmons B, Buckley C, Shibuya N, Jupiter D . Mortality After Nontraumatic Major Amputation Among Patients With Diabetes and Peripheral Vascular Disease: A Systematic Review. J Foot Ankle Surg. 2016; 55(3):591-9. DOI: 10.1053/j.jfas.2016.01.012. View

Criqui M, Aboyans V . Epidemiology of peripheral artery disease. Circ Res. 2015; 116(9):1509-26. DOI: 10.1161/CIRCRESAHA.116.303849. View

Engelbert T, Fernandes-Taylor S, Gupta P, Kent K, Matsumura J . Clinical characteristics associated with readmission among patients undergoing vascular surgery. J Vasc Surg. 2013; 59(5):1349-55. DOI: 10.1016/j.jvs.2013.10.103. View

Ciufo D, Thirukumaran C, Marchese R, Oh I . Risk factors for reoperation, readmission, and early complications after below knee amputation. Injury. 2018; 50(2):462-466. DOI: 10.1016/j.injury.2018.10.031. View

Wong L, Woelber E, Madison C, Nguyen K, Sangeorzan B, Meeker J . Mortality and Conversion to Transfemoral Amputation After Transtibial Amputation in the Veterans Affairs Health System. J Am Acad Orthop Surg. 2022; 30(16):798-807. DOI: 10.5435/JAAOS-D-22-00262. View

Vogel T, Smith J, Kruse R . Risk Factors for Thirty-Day Readmissions After Lower Extremity Amputation in Patients With Vascular Disease. PM R. 2018; 10(12):1321-1329. PMC: 6265125. DOI: 10.1016/j.pmrj.2018.05.017. View

10.

Falagas M, Kompoti M . Obesity and infection. Lancet Infect Dis. 2006; 6(7):438-46. DOI: 10.1016/S1473-3099(06)70523-0. View

11.

Wischmeyer P, Carli F, Evans D, Guilbert S, Kozar R, Pryor A . American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Nutrition Screening and Therapy Within a Surgical Enhanced Recovery Pathway. Anesth Analg. 2018; 126(6):1883-1895. DOI: 10.1213/ANE.0000000000002743. View

12.

Stoberock K, Kaschwich M, Nicolay S, Mahmoud N, Heidemann F, Riess H . The interrelationship between diabetes mellitus and peripheral arterial disease. Vasa. 2020; 50(5):323-330. DOI: 10.1024/0301-1526/a000925. View

13.

Goldberg J, Goodney P, Cronenwett J, Baker F . The effect of risk and race on lower extremity amputations among Medicare diabetic patients. J Vasc Surg. 2012; 56(6):1663-8. PMC: 3574810. DOI: 10.1016/j.jvs.2012.05.100. View

14.

Stern J, Wong C, Yerovinkina M, Spindler S, See A, Panjaki S . A Meta-analysis of Long-term Mortality and Associated Risk Factors following Lower Extremity Amputation. Ann Vasc Surg. 2017; 42:322-327. DOI: 10.1016/j.avsg.2016.12.015. View

15.

Arhuidese I, Nejim B, AJi E, Canner J, Malas M . Survival after major lower extremity amputation in patients with end-stage renal disease. J Vasc Surg. 2019; 70(4):1291-1298. DOI: 10.1016/j.jvs.2018.12.055. View

16.

Goodney P, Tarulli M, Faerber A, Schanzer A, Zwolak R . Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients. JAMA Surg. 2014; 150(1):84-6. PMC: 4303528. DOI: 10.1001/jamasurg.2014.1007. View

17.

Zayed M, Bech F, Hernandez-Boussard T . National review of factors influencing disparities and types of major lower extremity amputations. Ann Vasc Surg. 2013; 28(5):1157-65. DOI: 10.1016/j.avsg.2013.11.008. View

18.

Jones W, Patel M, Dai D, Vemulapalli S, Subherwal S, Stafford J . High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J. 2013; 165(5):809-15, 815.e1. DOI: 10.1016/j.ahj.2012.12.002. View

19.

Pei K, Zhang Y, Sarac T, Davis K . Comparison of Outcomes in Below-Knee Amputation between Vascular and General Surgeons. Ann Vasc Surg. 2018; 50:259-268. DOI: 10.1016/j.avsg.2017.11.073. View

20.

Holman K, Henke P, Dimick J, Birkmeyer J . Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg. 2011; 54(2):420-6, 426.e1. PMC: 3152619. DOI: 10.1016/j.jvs.2011.02.035. View